Skip to main content

Table 3 Cox regression models predicting individual components of MACE according to glycemic status, HTN, DLP

From: Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study

Category

HR (95% CI) for incident non-fatal MI

Unadjusted model

Adjusted model 1

Adjusted model 2

NFG/−HTN/−DLP

1.0

1.0

1.0

NFG/+HTN/+DLP

3.96 (1.69–9.26)

P = 0.002

4.34 (1.83–10.28)

P = 0.001

4.00 (1.63–9.83)

P = 0.002

IFG/−HTN/−DLP

0.90 (0.20–4.19)

P = 0.898

0.88 (0.19–4.07)

P = 0.871

0.87 (0.19–4.02)

P = 0.854

IFG/+HTN/+DLP

1.18 (0.26–5.48)

P = 0.830

1.31 (0.28–6.14)

P = 0.729

1.19 (0.25–5.68)

P = 0.831

DM/−HTN/−DLP

8.84 (3.15–24.84)

P = 0.000

8.94 (3.18–25.16)

P = 0.000

8.45 (2.92–24.46)

P = 0.000

DM/+HTN/+DLP

1.85 (0.50–6.84)

P = 0. 355

2.08 (0.56–7.79)

P = 0.275

1.88 (0.48–7.32)

P = 0.364

(IFG + DM)/−HTN/−DLP

2.77 (1.07–7.18)

P = 0.036

2.72 (1.05–7.05)

P = 0.040

2.59 (0.99–6.75)

P = 0.053

(IFG + DM)/+HTN/+DLP

1.51 (0.51–4.51)

P = 0.460

1.68 (0.55–5.07)

P = 0.361

1.41 (0.45–4.46)

P = 0.554

HR (95% CI) for incident non-fatal stroke

 Category

Unadjusted model

Adjusted model 1

Adjusted model 2

 NFG/−HTN/−DLP

1.0

1.0

1.0

 NFG/+HTN/+DLP

1.56 (0.66–3.73)

P = 0.312

1.40 (0.58–3.37)

P = 0.453

1. 36 (0.55–3.34)

P = 0.590

 IFG/−HTN/−DLP

0.58 (0.13–2.56)

P = 0.471

0.55 (0.13–2.43)

P = 0.431

0.54 (0.12–2.36)

P = 0.410

 IFG/+HTN/+DLP

3.75 (1.66–8.44)

P = 0.001

3.26 (1.43–7.43)

P = 0.005

3.18 (1.35–7.47)

P = 0.008

 DM/−HTN/−DLP

3.78 (1.24–11.47)

P = 0.019

3.52 (1.16–10.70)

P = 0.027

3.44 (1.12–10.59)

P = 0.031

 DM/+HTN/+DLP

5.07 (2.38–10.79)

P = 0.000

4.54 (2.11–9.77)

P = 0.001

4.30 (1.90–9.72)

P = 0.000

  (IFG + DM)/−HTN/−DLP

1.33 (0.51–3.46)

P = 0.558

1.26 (0.48–3.28)

P = 0.636

1.22 (0.47–3.18)

P = 0.687

  (IFG + DM)/+HTN/+DLP

4.40 (2.26–8.54)

P = 0.000

3.86 (1.96–7.62)

P = 0.000

3.61 (1.75–7.45)

P = 0.001

HR (95% CI) for incident CVD- death

 Category

Unadjusted model

Adjusted model 1

Adjusted model 2

 NFG/−HTN/−DLP

1.0

1.0

1.0

 NFG/+HTN/+DLP

2.96 (1.82–4.80)

P = 0.000

2.62(1.60–4.26)

P = 0.000

2.78 (1.68–4.61)

P = 0.000

 IFG/−HTN/−DLP

1.50 (0.77–2.92)

P = 0.229

1.40 (0.72–2.72)

P = 0.321

1.40 (0.72–2.72)

P = 0.322

 IFG/+HTN/+DLP

3.60 (2.09–6.19)

P = 0.000

3.05 (1.76–5.28)

P = 0.000

3.25 (1.84–5.74)

P = 0.000

 DM/−HTN/−DLP

3.35 (1.81–10.19)

P = 0.000

4.91 (2.58–9.37)

P = 0.000

5.22 (2.71–10.03)

P = 0.000

 DM/+HTN/+DLP

6.14 (3.81–9.89)

P = 0.000

4.48 (3.38–8.87)

P = 0.000

5.94 (3.55–9.95)

P = 0.000

  (IFG + DM)/−HTN/−DLP

2.40 (1.42–4.05)

P = 0.001

2.23 (1.32–3.77)

P = 0.003

2.24 (1.33–3.79)

P = 0.003

  (IFG + DM)/+HTN/+DLP

4.84 (3.14–7.46)

P = 0.000

4.20 (2.71–6.52)

P = 0.000

4.35 (2.73–6.94)

P = 0.000

  1. Model 1: adjusted for age + sex, Model 2: adjusted for age + sex + BMI + smoking (Never as reference). NFG Normal fasting glucose, IFG Impaired fasting glucose, HTN Hypertension, DLP Dyslipidemia